IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 40 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $122,000 | -65.5% | 71,103 | -50.4% | 0.00% | -70.0% |
| Q1 2017 | $354,000 | +181.0% | 143,471 | +70.8% | 0.01% | +233.3% |
| Q4 2016 | $126,000 | -33.7% | 84,019 | +13.0% | 0.00% | -40.0% |
| Q3 2016 | $190,000 | +40.7% | 74,351 | +8.8% | 0.01% | +25.0% |
| Q1 2016 | $135,000 | -67.1% | 68,325 | -48.5% | 0.00% | -42.9% |
| Q4 2015 | $410,000 | +572.1% | 132,571 | +705.2% | 0.01% | +600.0% |
| Q1 2015 | $61,000 | -7.6% | 16,464 | -43.2% | 0.00% | 0.0% |
| Q3 2014 | $66,000 | -36.5% | 28,986 | -19.6% | 0.00% | -50.0% |
| Q2 2014 | $104,000 | -32.9% | 36,045 | -4.8% | 0.00% | 0.0% |
| Q1 2014 | $155,000 | -26.9% | 37,844 | -17.6% | 0.00% | 0.0% |
| Q4 2013 | $212,000 | – | 45,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,550,000 | $16,437,000 | 2.17% |
| Ghost Tree Capital, LLC | 550,000 | $2,547,000 | 1.57% |
| HealthCor Management, L.P. | 3,350,000 | $15,511,000 | 0.94% |
| EAM Investors, LLC | 541,969 | $2,509,000 | 0.45% |
| Baker Brothers Advisors | 3,171,765 | $14,685,000 | 0.21% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 405,729 | $1,878,000 | 0.16% |
| Spark Investment Management LLC | 169,000 | $779,000 | 0.14% |
| CARL DOMINO INC | 50,137 | $232,000 | 0.13% |
| NATIXIS | 3,149,816 | $14,583,000 | 0.12% |
| HOLLENCREST CAPITAL MANAGEMENT | 132,000 | $611,000 | 0.10% |